Cargando…

A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study

BACKGROUND: SAKURA 3 was a Phase 3, open-label, repeat-dose safety study of DaxibotulinumtoxinA for Injection (DAXI); a component of the largest Phase 3 clinical development program of an aesthetic neuromodulator in glabellar lines. OBJECTIVE: To evaluate the use of DAXI (40U) up to 3 treatments for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Jeremy B., Mariwalla, Kavita, Coleman, Kyle, Ablon, Glynis, Weinkle, Susan H., Gallagher, Conor J., Vitarella, Domenico, Rubio, Roman G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752221/ https://www.ncbi.nlm.nih.gov/pubmed/32773447 http://dx.doi.org/10.1097/DSS.0000000000002463

Ejemplares similares

Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials
por: Solish, Nowell, et al.
Publicado: (2022)

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials
por: Gallagher, Conor J., et al.
Publicado: (2023)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
por: Fabi, Sabrina G., et al.
Publicado: (2021)

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines
por: Humphrey, Shannon, et al.
Publicado: (2023)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)
por: Carruthers, Jean D., et al.
Publicado: (2020)

Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position
por: Bertucci, Vince, et al.
Publicado: (2022)

Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program
por: Cohen, Joel L., et al.
Publicado: (2021)

Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection
por: Glogau, Richard, et al.
Publicado: (2021)

Bridging the Gap: Sustained Treatment Effect of Glabellar Lines With Twice-A-Year Treatment With DaxibotulinumtoxinA
por: Dover, Jeffrey S., et al.
Publicado: (2023)

Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2022)

Treatment of Upper Facial Lines With DaxibotulinumtoxinA for Injection: Results From an Open-Label Phase 2 Study
por: Dover, Jeffrey S., et al.
Publicado: (2023)

Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A
por: Solish, Nowell, et al.
Publicado: (2021)

DAXI (DaxibotulinumtoxinA) – An Innovative Approach for Frown Lines
por: Mussarat, Abdullah, et al.
Publicado: (2023)

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study
por: Jankovic, Joseph, et al.
Publicado: (2018)

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
por: Dayan, Steven, et al.
Publicado: (2022)

Sakura : tercinas del oriente remoto
por: Monterde, Francisco, 1894-1985
Publicado: (1963)

A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair
por: Ablon, Glynis
Publicado: (2015)

Long-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar
por: Kleiter, Ingo, et al.
Publicado: (2022)

Understanding How to Prevent and Treat Adverse Events of Fillers and Neuromodulators
por: Ablon, Glynis
Publicado: (2016)

Angiomyolipoma of the Glabellar Region
por: Kim, Hyo Joong, et al.
Publicado: (2017)

Sakura-based activated carbon preparation and its performance in supercapacitor applications
por: Ma, Fei, et al.
Publicado: (2019)

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

Optimizing Outcomes When Treating Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2023)

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

Physiology by Numbers, 2nd Edition
por: Mariwalla, Kavita
Publicado: (2001)

The complete mitochondrial genome sequence of the sakura shrimp, Sergia lucens (Crustacea, Decapoda, Sergestidae)
por: Kawato, Satoshi, et al.
Publicado: (2018)

Glabellar Presentation, Its Incidence and Termination
por: Mudaliar, A. L.
Publicado: (1934)

Glabellar flap technique in oculoplastic surgery
por: Balchev, Georgi, et al.
Publicado: (2022)

Glabellar and auricular leukemia cutis in CLL
por: Steinman, Bradley, et al.
Publicado: (2022)

Integrative Assessment for Optimizing Aesthetic Outcomes When Treating Glabellar Lines With Botulinum Toxin Type A: An Appreciation of the Role of the Frontalis
por: Bertucci, Vince, et al.
Publicado: (2022)

A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines
por: Punga, Anna Rostedt, et al.
Publicado: (2016)

Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
por: Nestor, Mark, et al.
Publicado: (2017)

Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
por: Wu, Yan, et al.
Publicado: (2022)

Commentary: A technical revisit to the glabellar flap
por: Singh, Manpreet, et al.
Publicado: (2022)

Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
por: Wu, Yan, et al.
Publicado: (2023)

Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry
por: Okumura, Yasuo, et al.
Publicado: (2017)

Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies
por: Beer, Kenneth R., et al.
Publicado: (2019)

Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat Reduction
por: Shridharani, Sachin M, et al.
Publicado: (2023)

Botulinum toxin type-A in the treatment of glabellar lines
por: Winter, Leslie, et al.
Publicado: (2009)

Botulinum toxin type A for the management of glabellar rhytids
por: Tremaine, Anne Marie, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ai585seb13m2638lqegb84hqok